| Completed | A Study of ASP8302 in Participants With Underactive Bladder Underactive Bladder | Phase 2 | 2018-11-20 |
| Completed | A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly Subjects Healthy Volunteers | Phase 1 | 2017-11-20 |
| Completed | A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Bladder Pain Syndrome, Interstitial Cystitis | Phase 2 | 2017-09-28 |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and E Healthy Volunteers | Phase 1 | 2017-05-23 |
| Terminated | A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Panto NSAID-induced Gastropathy | Phase 4 | 2017-03-03 |
| Completed | A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function Normal Renal Function, Impaired Renal Function | Phase 1 | 2016-12-12 |
| Completed | Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detru Neurogenic Detrusor Overactivity | Phase 3 | 2016-06-17 |
| Completed | A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Type 2 Diabetes Mellitus | Phase 3 | 2016-05-11 |
| Completed | A Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee Osteoarthritis of the Knee, Chronic Lower Back Pain | Phase 2 | 2016-02-16 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intr Healthy Subjects, Pharmacokinetics of ASP6294 | Phase 1 | 2016-01-01 |
| Completed | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric S Overactive Bladder, Neurogenic Detrusor Overactivity | Phase 1 | 2015-12-17 |
| Completed | A Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry i Healthy Subjects | Phase 1 | 2015-05-01 |
| Completed | First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of P Healthy Volunteers | Phase 1 | 2015-05-01 |
| Completed | A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Chronic Kidney Disease, Type 2 Diabetes | Phase 2 | 2015-03-17 |
| Completed | A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME Diabetes Mellitus, Diabetic Macular Edema | Phase 2 | 2015-01-12 |
| Completed | A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Ora Clostridium Difficile-associated Diarrhea (CDAD) | Phase 3 | 2015-01-09 |
| Completed | A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects Healthy Volunteers | Phase 1 | 2015-01-01 |
| Completed | Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis Anemia, End Stage Renal Disease (ESRD) | Phase 3 | 2014-11-21 |
| Terminated | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2205 in Healthy Young Males and Females Healthy Subjects, Pharmacokinetics of ASP2205 | Phase 1 | 2014-11-01 |
| Withdrawn | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3700 in Healthy Subjec Healthy Volunteers, Pharmacokinetics of ASP3700 | Phase 1 | 2014-11-01 |
| Completed | A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cance Castration-Resistant Prostate Cancer, Prostate Cancer | Phase 2 | 2014-09-23 |
| Completed | A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics Urinary Bladder, Overactive | — | 2014-06-01 |
| Completed | A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer Metastatic Castration-Resistant Prostate Cancer | Phase 4 | 2014-05-23 |
| Completed | Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentration Healthy Subjects, Pharmacokinetics, Drug-Drug Interaction (DDI) | Phase 1 | 2014-05-01 |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Multiple Ascending Doses of ASP7962 in Healthy Volunteers, Pharmacokinetics of ASP7962 | Phase 1 | 2014-05-01 |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects Healthy Volunteers, Pharmacokinetics of ASP3700 | Phase 1 | 2014-05-01 |
| Terminated | A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmac Pharmacokinetics of ASP7657, Pharmacodynamics of ASP7657, Healthy Subjects | Phase 1 | 2014-04-01 |
| Completed | A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female Subjects Pharmacokinetics, DDI (Drug-Drug Interaction), Healthy Subjects | Phase 1 | 2014-04-01 |
| Completed | A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Urinary Bladder Overactive, Overactive Bladder, Urgency Incontinence | Phase 3 | 2014-03-17 |
| Completed | Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison Anemia in Chronic Kidney Disease in Non-dialysis Patients | Phase 3 | 2014-03-12 |
| Completed | Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy S Healthy Subjects, Pharmacokinetics, Drug-Drug Interaction (DDI) | Phase 1 | 2014-03-01 |
| Completed | A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or P Post-Herpetic Neuralgia (PHN), Neuropathic Pain, Painful Diabetic Peripheral Neuropathy (PDPN) | Phase 2 | 2014-02-24 |
| Completed | This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Urinary Bladder Overactive, Urinary Bladder Diseases\Urologic Diseases, Overactive Bladder | Phase 3 | 2013-11-05 |
| Completed | A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans Safety, Tolerability, Pharmacokinetics of ASP7962 | Phase 1 | 2013-11-01 |
| Completed | A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan Pharmacokinetics of Dextromethorphan, Pharmacokinetics of Caffeine, Prostate Cancer | Phase 1 | 2013-10-02 |
| Completed | A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effec Neurogenic Detrusor Overactivity, Pediatric | Phase 3 | 2013-09-25 |
| Completed | A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impair Healthy Subjects, Pharmacokinetics of ASP8232, Pharmacodynamics of ASP8232 | Phase 1 / Phase 2 | 2013-09-16 |
| Completed | Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis Anemia in Chronic Kidney Disease in Non-dialysis Patients | Phase 3 | 2013-09-03 |
| Completed | An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Advanced Prostate Carcinoma | — | 2013-09-01 |
| Completed | A Study to Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Fema PK for FG-4592, Healthy Subjects | Phase 1 | 2013-09-01 |
| Completed | A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With M PK of FG-4592, Hepatic Insufficiency, Healthy Subjects | Phase 1 | 2013-09-01 |
| Completed | A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effe Pharmacokinetics of FG-4592, Healthy Subjects | Phase 1 | 2013-09-01 |
| Completed | A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerab Severe Hepatic Impairment, Normal Hepatic Function | Phase 1 | 2013-08-01 |
| Completed | A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Drug-Drug Interaction (DDI), Healthy Subjects, Pharmacokinetics of Enzalutamide | Phase 1 | 2013-07-01 |
| Completed | A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Mal Drug-Drug Interaction (DDI), Intestinal Absorption, Healthy Subjects | Phase 1 | 2013-02-01 |
| Completed | A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometri Endometriosis | Phase 2 | 2012-12-04 |
| Completed | Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients Prostate Cancer, Pharmacokinetics of Enzalutamide | Phase 1 | 2012-11-01 |
| Completed | A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dos Healthy Subjects, Castration Resistant Prostate Cancer (CRPC), Relative Bioavailability | Phase 1 | 2012-11-01 |
| Completed | A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Sy Urinary Bladder, Overactive | Phase 3 | 2012-10-04 |
| Completed | Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents Systemic Fungal Infections | — | 2012-10-01 |
| Completed | A Study to Investigate the Appearance and Disappearance of ASP3652 in Blood and Spinal Fluid in Healthy Male S Pharmacokinetics of ASP3652, Pharmacodynamics of ASP3652, Healthy Subjects | Phase 1 | 2012-09-01 |
| Completed | A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Phase 1, Bioavailability, Healthy Subjects | Phase 1 | 2012-09-01 |
| Completed | A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participan Neurogenic Detrusor Overactivity | Phase 3 | 2012-08-14 |
| Completed | A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subject Pharmacokinetics, Pharmacodynamics, Healthy Subjects | Phase 1 | 2012-08-01 |
| Completed | A Study to Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Pharmacokinetics, Pharmacodynamics, Healthy Subjects | Phase 1 | 2012-07-01 |
| Completed | A Study to Assess the Pharmacokinetics, Metabolism and Excretion Routes of ASP3652 in Man, After Administratio Healthy Subjects, Pharmacokinetics of ASP3652 | Phase 1 | 2012-07-01 |
| Completed | A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolesc Urinary Bladder, Overactive | Phase 3 | 2012-06-07 |
| Completed | Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia | — | 2012-06-01 |
| Completed | A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Inters Cystitis, Interstitial, Urinary Bladder Disease, Pain | Phase 2 | 2012-05-31 |
| Completed | Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma Lymphoma, Non-Hodgkin | — | 2012-05-01 |
| Completed | A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the E Drug-Drug Interaction (DDI), Healthy Subjects | Phase 1 | 2012-04-01 |
| Terminated | To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Diffic Clostridium Difficile | — | 2012-03-01 |
| Completed | Treatment of Symptoms in Male Patients With Lower Urinary Tract Symptoms (LUTS) Predominant Storage Symptoms ( Lower Urinary Tract Predominant Storage Symptoms | — | 2011-12-01 |
| Completed | Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg Prostate Cancer | — | 2011-12-01 |
| Completed | A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin Type 2 Diabetes Mellitus | Phase 1 | 2011-10-27 |
| Completed | Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Heal Pharmacokinetics of MDV3100, Healthy Subjects, Kidney Diseases | Phase 1 | 2011-10-01 |
| Completed | A Study to Evaluate the Effect of ASP1707 on the Bodies of Healthy Male Subjects After a Single Dose of Radioa Pharmacokinetics of ASP1707 | Phase 1 | 2011-08-01 |
| Completed | Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and Itraconazole Healthy Subjects, Pharmacokinetics, Drug-Drug Interaction | Phase 1 | 2011-08-01 |
| Completed | Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates Pharmacokinetics of MDV3100, Castration Resistant Prostate Cancer (CRPC) | Phase 1 | 2011-07-25 |
| Completed | Drug to Drug Interaction Study With Ipragliflozin and Furosemide Healthy Subjects, Pharmacokinetics of Ipragliflozin | Phase 1 | 2011-07-01 |
| Completed | A Study to Assess the Effects of Single Ascending Doses of ASP1707 in Healthy Young Japanese Male Subjects Healthy Subjects | Phase 1 | 2011-06-01 |
| Completed | Absolute Bioavailability Study With Ipragliflozin Bioavailability of Ipragliflozin, Healthy Subjects | Phase 1 | 2011-06-01 |
| Completed | A Study to Explore the Routes of Elimination of MDV3100 Healthy Subjects, Pharmacokinetics of MDV3100 | Phase 1 | 2011-04-01 |
| Completed | A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Urologic Diseases, Urinary Bladder Diseases, Urological Manifestations | Phase 2 | 2011-03-29 |
| Completed | A Study to Assess the Effects of Single Ascending Doses (SAD) of ASP8477, the Effect That Food Has on the Drug Pharmacokinetics of ASP8477, Pharmacodynamics of ASP8477 | Phase 1 | 2010-11-01 |
| Completed | A Study to Assess the Safety, Tolerability and Effects of Single and Multiple Ascending Doses of ASP1707 in He Pharmacokinetics of ASP1707, Pharmacodynamics of ASP1707 | Phase 1 | 2010-06-01 |
| Completed | Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia | Phase 3 | 2010-04-26 |
| Completed | A Study to Evaluate How Tamsulosin (at 1 Dose) and Solifenacin (at 2 Different Doses) Are Taken up From the In EC905, Pharmacokinetics, Multiple Dose | Phase 1 | 2010-04-01 |
| Completed | A Study to Evaluate Whether Food Has an Effect on the Uptake of Solifenacin and Tamsulosin When Administered i EC905, Pharmacokinetics, Healthy Subjects | Phase 1 | 2010-04-01 |
| Completed | A Study to Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tams EC905, Pharmacokinetics, Healthy Subjects | Phase 1 | 2010-03-01 |
| Completed | Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms | Phase 3 | 2010-01-11 |
| Completed | Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes Acute Coronary Syndrome | Phase 2 | 2009-09-01 |
| Completed | A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosi Drug-Drug Interaction (DDI), Healthy Subjects | Phase 1 | 2009-08-01 |
| Completed | A Study to Assess the Safety, Tolerability, and Effects in and on the Body of Healthy Young and Elderly Male a Healthy Subjects, Pharmacokinetics of ASP3652, Pharmacodynamics of ASP3652 | Phase 1 | 2009-05-01 |
| Completed | A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Venous Thromboembolism, Arthroplasty, Replacement, Hip | Phase 2 / Phase 3 | 2009-04-01 |
| Completed | EC905 Pharmacokinetic Profile Study Phase 1, Healthy, Benign Prostatic Hyperplasia | Phase 1 | 2009-03-01 |
| Completed | A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment C Pharmacokinetics, Healthy Subjects, Mild and Moderate Hepatic Impairment | Phase 1 | 2008-11-01 |
| Completed | A Study to Evaluate the Effect of a Single Dose of Digoxin on the Actions in the Bodies of Healthy Subjects Af Healthy | Phase 1 | 2008-09-01 |
| Completed | Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatit Dermatitis, Atopic | Phase 4 | 2008-03-01 |
| Completed | A Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male Subjects Pharmacokinetics, Healthy Male Subjects | Phase 1 | 2007-02-01 |
| Completed | A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Sub Pharmacokinetics, Pharmacodynamics, Healthy Subjects | Phase 1 | 2006-06-01 |
| Completed | A Study to Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Pharmacokinetics of YM178, Healthy Subjects | Phase 1 | 2005-01-01 |
| Completed | Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder Urinary Bladder, Overactive | Phase 2 | 2004-04-05 |
| Completed | A Study to Assess the Systemic Pharmacokinetics, Metabolism and Excretion Routes of YM178 in Man, After Admini Metabolic Processes | Phase 1 | 2003-01-01 |